AI frontier will shift to chip design, drugs, and robotics
Aravind Srinivas · Perplexity CEO: Micron Will Be More Valuable Than Meta & How Export Controls Helped Not Hurt China · 20VC with Harry Stebbings · Jun 15, 2026 · at 23:59
Aravind Srinivas is the founder and CEO of Perplexity AI. He discusses the long-term direction of frontier AI development beyond digital software tasks.
0:00 / 0:29exact quote · 29.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Whatever is the frontier is going to be things that Kind of like AI is going and designing chips. AI is designing drugs. AI is figuring out how to build robots. AI is figuring out how to cure cancer. These are applications where you don't have like, ten million users. It's like a few companies, but the effect of that work will touch a lot of human lives. I think to me that that's where the frontier is headed.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Aravind Srinivas
Anthropic will die within 12 months if complacent on Claude Code
“If Anthropic thinks cloud code is already a win, In six or 12 months from now, they won't even be around.”
AI agents will generate more revenue than Google or Meta ads
“These products are not going to be used by you know, a hundred million people. But they will generate revenue that's going to be higher than the advertising revenue of Google or Meta. It's going to happen.”
Srinivas: Anthropic is algorithmically superior to OpenAI
“Anthropic because they're algorithmically a superior company. Like they got whatever open AI got to with lower capital. They have better post training and like things like that.”
Srinivas: Google failed to align user experience and shareholder interests
“This is where Google got it wrong because asymptotically they couldn't achieve that alignment between the user that is you using Google and the shareholder. Wall Street loves it when Google puts more ads. You hate it.”